{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T09:39:58Z","timestamp":1756460398399},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,31]],"date-time":"2016-12-31T00:00:00Z","timestamp":1483142400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.nrl.2016.01.004","type":"journal-article","created":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T19:06:27Z","timestamp":1457463987000},"page":"133-135","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["S\u00edndrome de parkinsonismo-hiperpirexia"],"prefix":"10.1016","volume":"33","author":[{"given":"J.L.","family":"Camacho Vel\u00e1squez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Rivero Sanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Cruz Tabuenca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"L\u00f3pez del Val","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Mauri Llerda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrl.2016.01.004_bib0075","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00005053-198105000-00011","article-title":"Neuroleptic malignant syndrome-like state following a withdrawal of antiparkinsonian drugs","volume":"169","author":"Toru","year":"1981","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.nrl.2016.01.004_bib0080","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/gps.1441","article-title":"Neuroleptic malignant like syndrome in two patients on cholinesterase inhibitors","volume":"21","author":"Grace","year":"2006","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.nrl.2016.01.004_bib0085","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1176\/ajp.141.6.796","article-title":"Case report of neuroleptic malignant syndrome associated with withdrawal from amantadine","volume":"141","author":"Simpson","year":"1984","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.nrl.2016.01.004_bib0090","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/mds.23596","article-title":"Case report: Recurrent parkinsonism-hyperpyrexia syndrome following discontinuation of subthalamic deep brain stimulation","volume":"26","author":"Kadowaki","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.nrl.2016.01.004_bib0095","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/ageing\/afl096","article-title":"It was not just a heatwave! Neuroleptic malignant-like syndrome in a patient with Parkinson's disease","volume":"35","author":"Douglas","year":"2006","journal-title":"Age Ageing"},{"issue":"Suppl 1","key":"10.1016\/j.nrl.2016.01.004_bib0100","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S1353-8020(02)00125-6","article-title":"Malignant syndrome in Parkinson's disease: Concept and review of the literature","author":"Mizuno","year":"2003","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.nrl.2016.01.004_bib0105","doi-asserted-by":"crossref","unstructured":"Factor SA, Santiago A. Parkinsonism-hyperpyrexia syndrome in Parkinson's disease. En: Movement disorder emergencies: Diagnosis and treatment. New York: Humana Press; 2005. p. 29-41.","DOI":"10.1385\/1-59259-902-8:029"},{"key":"10.1016\/j.nrl.2016.01.004_bib0110","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/jnnp.71.1.111","article-title":"Biochemical alterations during medication withdrawal in Parkinson's disease with and without neuroleptic malignant-like syndrome","volume":"71","author":"Ueda","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nrl.2016.01.004_bib0115","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s12028-008-9125-4","article-title":"The parkinsonism-hyperpyrexia syndrome","volume":"10","author":"Newman","year":"2009","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.nrl.2016.01.004_bib0120","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00002826-200207000-00001","article-title":"Is neuroleptic malignant syndrome a neurogenic form of malignant hyperthermia?","volume":"25","author":"Gurrera","year":"2002","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.nrl.2016.01.004_bib0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0447.1990.tb06439.x","article-title":"The neuroleptic malignant syndrome and its differentiation from lethal catatonia","volume":"81","author":"Fleischhacker","year":"1990","journal-title":"Acta Psychiatr Scand."},{"key":"10.1016\/j.nrl.2016.01.004_bib0130","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1002\/mds.23255","article-title":"Dyskinesia-hyperpyrexia syndrome: Another Parkinson's disease emergency","volume":"25","author":"Gil-Navarro","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.nrl.2016.01.004_bib0135","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jocn.2005.09.017","article-title":"Parkinsonism-hyperpyrexia syndrome: The role of electroconvulsive therapy","volume":"13","author":"Meagher","year":"2006","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.nrl.2016.01.004_bib0140","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/jnnp.74.5.574","article-title":"Efficacy of methylprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson's disease","volume":"74","author":"Sato","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Neurolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485316000505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485316000505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T13:30:09Z","timestamp":1530019809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213485316000505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0213485316000505"],"URL":"https:\/\/doi.org\/10.1016\/j.nrl.2016.01.004","relation":{},"ISSN":["0213-4853"],"issn-type":[{"value":"0213-4853","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"S\u00edndrome de parkinsonismo-hiperpirexia","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrl.2016.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}